New drug hope for brain inflammation patients
NCT ID NCT07583641
First seen May 21, 2026 · Last updated May 21, 2026
Summary
This study tests a drug called efgartigimod for people with autoimmune encephalitis, a condition where the immune system attacks the brain. About 170 adults and teens will receive either the drug or a placebo to see if it improves symptoms like memory loss, seizures, and weakness. The study lasts up to 3 years and includes a follow-up period where treatment can be restarted if symptoms return.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE ENCEPHALITIS (AE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.